Ortin Global Limited (NSE:ORTINGLOBE)

Market Cap	111.81M -15.2%
Revenue (ttm)	1.12M -79.6%
Net Income	-8.95M
EPS	-1.10
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,273
Average Volume	8,415
Open	14.57
Previous Close	15.33
Day's Range	14.57 - 16.09
52-Week Range	10.32 - 19.90
Beta	0.52
RSI	53.14
Earnings Date	May 29, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 3
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORTINGLOBE

Financial Performance

In fiscal year 2025, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2024.